{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:48:28Z","timestamp":1780598908610,"version":"3.54.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1080,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Blue Cross Blue Shield"},{"name":"Blue Cross Blue Shield"},{"name":"Blue Cross Blue Shield"},{"name":"University of Michigan Medical Center"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.jcin.2010.05.013","type":"journal-article","created":{"date-parts":[[2010,8,19]],"date-time":"2010-08-19T05:27:39Z","timestamp":1282195659000},"page":"845-850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Retroperitoneal Hematoma After Percutaneous Coronary Intervention: Prevalence, Risk Factors, Management, Outcomes, and Predictors of Mortality"],"prefix":"10.1016","volume":"3","author":[{"given":"Santi","family":"Trimarchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Share","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep M.","family":"Jani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Riba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kline-Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitinder S.","family":"Gurm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Moscucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2010.05.013_bib1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0741-5214(94)90227-5","article-title":"Retroperitoneal hematoma after cardiac catheterization: prevalence, risk factors, and optimal management","volume":"20","author":"Kent","year":"1994","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jcin.2010.05.013_bib2","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0002-9149(02)02771-6","article-title":"Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose","volume":"90","author":"Freeman","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2010.05.013_bib3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0002-9149(94)90901-6","article-title":"Peripheral vascular complications of directional coronary atherectomy and stenting: predictors, management, and outcome","volume":"74","author":"Moscucci","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2010.05.013_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7326\/0003-4819-139-2-200307150-00012","article-title":"Management of patients undergoing percutaneous coronary revascularization","volume":"139","author":"Levine","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcin.2010.05.013_bib5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jacc.2004.10.042","article-title":"Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb\/IIIa inhibitors and vascular closure devices","volume":"45","author":"Farouque","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2010.05.013_bib6","first-page":"1200","article-title":"Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis","volume":"44","author":"Nikolsky","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2010.05.013_bib7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1540-8183.2002.tb01071.x","article-title":"The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) collaborative quality improvement initiative in percutaneous coronary interventions","volume":"15","author":"Moscucci","year":"2002","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.jcin.2010.05.013_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1540-8183.2002.tb01072.x","article-title":"Development of a multicenter interventional cardiology database: the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) experience","volume":"15","author":"Kline-Rogers","year":"2002","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.jcin.2010.05.013_bib9","first-page":"94","article-title":"Retroperitoneal hematoma following femoral arterial catheterization: a serious and often fatal complication","volume":"59","author":"Sreeram","year":"1993","journal-title":"Am Surg"},{"key":"10.1016\/j.jcin.2010.05.013_bib10","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0002-9149(03)00972-X","article-title":"Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions","volume":"92","author":"Kinnaird","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2010.05.013_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ahj.2003.07.019","article-title":"Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices","volume":"147","author":"Exaire","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2010.05.013_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/153857440103500307","article-title":"Changing patterns of access site complications with the use of percutaneous closure devices","volume":"35","author":"Toursarkissian","year":"2001","journal-title":"Vasc Surg"},{"key":"10.1016\/j.jcin.2010.05.013_bib13","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1067\/mva.2001.112324","article-title":"The management of peripheral vascular complications associated with the use of percutaneous suture-mediated closure devices","volume":"33","author":"Sprouse","year":"2001","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jcin.2010.05.013_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0002-9149(97)00796-0","article-title":"Vascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) trial","volume":"81","author":"Blankenship","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2010.05.013_bib15","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0735-1097(98)00130-2","article-title":"Modifiable risk factors for vascular access site complications in the IMPACT II trial of angioplasty with versus without eptifibatide","volume":"31","author":"Mandak","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2010.05.013_bib16","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jama.289.7.853","article-title":"Bivalirudin and provisional glycoprotein IIb\/IIIa blockade compared with heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial","volume":"289","author":"Lincoff","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2010.05.013_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0735-1097(94)90305-0","article-title":"Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women","volume":"24","author":"Celermajer","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2010.05.013_bib18","first-page":"289","article-title":"Common femoral artery anatomy is influenced by demographics and comorbidity: implications for cardiac and peripheral invasive studies","volume":"53","author":"Schnyder","year":"2001","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2010.05.013_bib19","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0735-1097(01)01166-4","article-title":"Comparative effects of aging in men and women on the properties of the arterial tree","volume":"37","author":"Smulyan","year":"2001","journal-title":"J Am Coll Cardiol"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879810003845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879810003845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:56:48Z","timestamp":1761847008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879810003845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S1936879810003845"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2010.05.013","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retroperitoneal Hematoma After Percutaneous Coronary Intervention: Prevalence, Risk Factors, Management, Outcomes, and Predictors of Mortality","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2010.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}